Human malignant brain tumor response to herpes simplex thymidine kinase (HSVtk)/ganciclovir gene therapy

Gene Therapy

Volumn 3, Issue 6, 1996, Pages 491-495

  Izquierdo, M ^a   Martin V ^a   De Felipe, P ^a   Izquierdo, J M ^b   Perez Higueras A ^c   Cortes M L ^a   Paz, J F ^d   Isla, A ^d   Blazquez M G ^d  

^a UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

^b HOSPITAL UNIVERSITARIO MARQUÉS DE VALDECILLA   (Spain)

^c Clin Concepcion   (Spain)

^d HOSPITAL UNIVERSITARIO LA PAZ   (Spain)

Author keywords

Glioblastoma explants; HSVtk ganciclovir treatment; Human gene therapy; Malignant brain tumor; Therapeutic retrovirus

Indexed keywords

GANCICLOVIR; THYMIDINE KINASE;

AGED; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN TUMOR; CANCER SURVIVAL; CELL DEATH; CLINICAL ARTICLE; CONTROLLED STUDY; GENE THERAPY; HERPES SIMPLEX VIRUS; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; RAT; RETROVIRUS; TUMOR CELL;

3T3 CELLS; ADULT; ANIMALS; ANTIVIRAL AGENTS; BRAIN NEOPLASMS; CELL DEATH; COCULTURE TECHNIQUES; FIBROBLASTS; GANCICLOVIR; GENE THERAPY; GLIOBLASTOMA; HUMANS; MAGNETIC RESONANCE IMAGING; MICE; NEOPLASM RECURRENCE, LOCAL; POLYMERASE CHAIN REACTION; RATS; SIMPLEXVIRUS; SURVIVAL ANALYSIS; THYMIDINE KINASE; TRANSFECTION; TUMOR CELLS, CULTURED;

EID: 0029992327     PISSN: 09697128     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. Moolten FL. Tumor chemosensitivity conferred by inserted herpes thymidine kinase genes: paradigm for a prospective cancer control strategy. Cancer Res 1986; 46: 5276-5281.
2. Moolten FL, Wells JM, Heyman RA, Evans RM. Lymphoma regression induced by ganciclovir in mice being a herpes thymidine kinase transgene. Hum Gene Ther 1990; 1: 125-135.
3. Short MP et al. Gene delivery to glioma cells in rat brain by grafting of a retrovirus packaging cell line. J Neurosci Res 1990; 27: 427-433.
4. Takamiya Y et al. Gene therapy of malignant brain tumors: a rat glioma line bearing the herpes simplex virus type 1-thymidine kinase gene and wild type retrovirus kills other tumor cells. J Neurosci Res 1992; 33: 493-503.
5. Culver KW et al. In vivo gene transfer with retroviral vector-producer cells for treatment of experimental brain tumors. Science 1992; 256: 1550-1552.
6. Ram Z et al. In situ retroviral-mediated gene transfer for the treatment of brain tumors in rats. Cancer Res 1993; 53: 83-88.
7. Izquierdo M et al. Long-term rat survival after malignant brain tumor regression by retroviral gene therapy. Gene Therapy 1995; 2: 66-69.
8. Danos O, Mulligan RC. Safe and efficient generation of recombinant retroviruses with amphotropic and ecotropic host ranges. Proc Natl Acad Sci USA 1988; 85: 6460-6464.
9. Cepko CL, Roberts BE, Mulligan RC. Construction and applications of a highly transmissible murine retrovirus shuttle vector Cell 1984; 37: 1053-1062.
10. Miller AD, Miller DG, García JV, Lynch CM. Use of retroviral vectors for gene transfer and expression. Meth Enzymol 1993; 217: 581-599.
11. Miller AD, Rosman GJ. Improved retroviral vectors for gene transfer and expression. BioTechniques 1989; 7: 980-990.
12. Ram Z et al. Toxicity studies of retroviral-mediated gene transfer for the treatment of brain tumors. J Neurosurg 1993; 79: 400-407.
13. Culver K et al. Gene therapy for the treatment of malignant brain tumors with in vivo tumor transduction with herpes simplex thymidine kinase gene/ganciclovir system. Hum Gene Ther 1994; 5. 343-379.